Global Active Transdermal Drug Delivery Device Market Insights and Forecast to 2031

Report ID: 1564455 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Active Transdermal Drug Delivery Device Product Introduction
    1.2 Market by Type
        1.2.1 Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Patches
        1.2.3 Gels
    1.3 Market by Application
        1.3.1 Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Home Use
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Active Transdermal Drug Delivery Device Sales Estimates and Forecasts 2017-2028
    2.2 Global Active Transdermal Drug Delivery Device Revenue Estimates and Forecasts 2017-2028
    2.3 Global Active Transdermal Drug Delivery Device Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Active Transdermal Drug Delivery Device Sales by Region
        2.4.1 Global Active Transdermal Drug Delivery Device Sales by Region (2017-2022)
        2.4.2 Global Sales Active Transdermal Drug Delivery Device by Region (2023-2028)
    2.5 Global Active Transdermal Drug Delivery Device Revenue by Region
        2.5.1 Global Active Transdermal Drug Delivery Device Revenue by Region (2017-2022)
        2.5.2 Global Active Transdermal Drug Delivery Device Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Active Transdermal Drug Delivery Device Sales by Manufacturers
        3.1.1 Global Top Active Transdermal Drug Delivery Device Manufacturers by Sales (2017-2022)
        3.1.2 Global Active Transdermal Drug Delivery Device Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Active Transdermal Drug Delivery Device in 2021
    3.2 Global Active Transdermal Drug Delivery Device Revenue by Manufacturers
        3.2.1 Global Active Transdermal Drug Delivery Device Revenue by Manufacturers (2017-2022)
        3.2.2 Global Active Transdermal Drug Delivery Device Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Active Transdermal Drug Delivery Device Revenue in 2021
    3.3 Global Active Transdermal Drug Delivery Device Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Active Transdermal Drug Delivery Device Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Active Transdermal Drug Delivery Device Sales by Type
        4.1.1 Global Active Transdermal Drug Delivery Device Historical Sales by Type (2017-2022)
        4.1.2 Global Active Transdermal Drug Delivery Device Forecasted Sales by Type (2023-2028)
        4.1.3 Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2028)
    4.2 Global Active Transdermal Drug Delivery Device Revenue by Type
        4.2.1 Global Active Transdermal Drug Delivery Device Historical Revenue by Type (2017-2022)
        4.2.2 Global Active Transdermal Drug Delivery Device Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2028)
    4.3 Global Active Transdermal Drug Delivery Device Price by Type
        4.3.1 Global Active Transdermal Drug Delivery Device Price by Type (2017-2022)
        4.3.2 Global Active Transdermal Drug Delivery Device Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Active Transdermal Drug Delivery Device Sales by Application
        5.1.1 Global Active Transdermal Drug Delivery Device Historical Sales by Application (2017-2022)
        5.1.2 Global Active Transdermal Drug Delivery Device Forecasted Sales by Application (2023-2028)
        5.1.3 Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2028)
    5.2 Global Active Transdermal Drug Delivery Device Revenue by Application
        5.2.1 Global Active Transdermal Drug Delivery Device Historical Revenue by Application (2017-2022)
        5.2.2 Global Active Transdermal Drug Delivery Device Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2028)
    5.3 Global Active Transdermal Drug Delivery Device Price by Application
        5.3.1 Global Active Transdermal Drug Delivery Device Price by Application (2017-2022)
        5.3.2 Global Active Transdermal Drug Delivery Device Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Active Transdermal Drug Delivery Device Market Size by Type
        6.1.1 North America Active Transdermal Drug Delivery Device Sales by Type (2017-2028)
        6.1.2 North America Active Transdermal Drug Delivery Device Revenue by Type (2017-2028)
    6.2 North America Active Transdermal Drug Delivery Device Market Size by Application
        6.2.1 North America Active Transdermal Drug Delivery Device Sales by Application (2017-2028)
        6.2.2 North America Active Transdermal Drug Delivery Device Revenue by Application (2017-2028)
    6.3 North America Active Transdermal Drug Delivery Device Market Size by Country
        6.3.1 North America Active Transdermal Drug Delivery Device Sales by Country (2017-2028)
        6.3.2 North America Active Transdermal Drug Delivery Device Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Active Transdermal Drug Delivery Device Market Size by Type
        7.1.1 Europe Active Transdermal Drug Delivery Device Sales by Type (2017-2028)
        7.1.2 Europe Active Transdermal Drug Delivery Device Revenue by Type (2017-2028)
    7.2 Europe Active Transdermal Drug Delivery Device Market Size by Application
        7.2.1 Europe Active Transdermal Drug Delivery Device Sales by Application (2017-2028)
        7.2.2 Europe Active Transdermal Drug Delivery Device Revenue by Application (2017-2028)
    7.3 Europe Active Transdermal Drug Delivery Device Market Size by Country
        7.3.1 Europe Active Transdermal Drug Delivery Device Sales by Country (2017-2028)
        7.3.2 Europe Active Transdermal Drug Delivery Device Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Active Transdermal Drug Delivery Device Market Size by Type
        8.1.1 Asia Pacific Active Transdermal Drug Delivery Device Sales by Type (2017-2028)
        8.1.2 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Type (2017-2028)
    8.2 Asia Pacific Active Transdermal Drug Delivery Device Market Size by Application
        8.2.1 Asia Pacific Active Transdermal Drug Delivery Device Sales by Application (2017-2028)
        8.2.2 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Application (2017-2028)
    8.3 Asia Pacific Active Transdermal Drug Delivery Device Market Size by Region
        8.3.1 Asia Pacific Active Transdermal Drug Delivery Device Sales by Region (2017-2028)
        8.3.2 Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Active Transdermal Drug Delivery Device Market Size by Type
        9.1.1 Latin America Active Transdermal Drug Delivery Device Sales by Type (2017-2028)
        9.1.2 Latin America Active Transdermal Drug Delivery Device Revenue by Type (2017-2028)
    9.2 Latin America Active Transdermal Drug Delivery Device Market Size by Application
        9.2.1 Latin America Active Transdermal Drug Delivery Device Sales by Application (2017-2028)
        9.2.2 Latin America Active Transdermal Drug Delivery Device Revenue by Application (2017-2028)
    9.3 Latin America Active Transdermal Drug Delivery Device Market Size by Country
        9.3.1 Latin America Active Transdermal Drug Delivery Device Sales by Country (2017-2028)
        9.3.2 Latin America Active Transdermal Drug Delivery Device Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Active Transdermal Drug Delivery Device Market Size by Type
        10.1.1 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Type (2017-2028)
    10.2 Middle East and Africa Active Transdermal Drug Delivery Device Market Size by Application
        10.2.1 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Application (2017-2028)
    10.3 Middle East and Africa Active Transdermal Drug Delivery Device Market Size by Country
        10.3.1 Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novartis AG
        11.1.1 Novartis AG Corporation Information
        11.1.2 Novartis AG Overview
        11.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novartis AG Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novartis AG Recent Developments
    11.2 Noven Pharmaceuticals, Inc.
        11.2.1 Noven Pharmaceuticals, Inc. Corporation Information
        11.2.2 Noven Pharmaceuticals, Inc. Overview
        11.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Noven Pharmaceuticals, Inc. Recent Developments
    11.3 Transdermal Corp.
        11.3.1 Transdermal Corp. Corporation Information
        11.3.2 Transdermal Corp. Overview
        11.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Transdermal Corp. Recent Developments
    11.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
        11.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
        11.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Overview
        11.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments
    11.5 Mylan N.V.
        11.5.1 Mylan N.V. Corporation Information
        11.5.2 Mylan N.V. Overview
        11.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Mylan N.V. Recent Developments
    11.6 3M
        11.6.1 3M Corporation Information
        11.6.2 3M Overview
        11.6.3 3M Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 3M Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 3M Recent Developments
    11.7 Actavis, Inc.
        11.7.1 Actavis, Inc. Corporation Information
        11.7.2 Actavis, Inc. Overview
        11.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Actavis, Inc. Recent Developments
    11.8 Bayer AG
        11.8.1 Bayer AG Corporation Information
        11.8.2 Bayer AG Overview
        11.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Bayer AG Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Bayer AG Recent Developments
    11.9 Boehringer Ingelheim GmbH
        11.9.1 Boehringer Ingelheim GmbH Corporation Information
        11.9.2 Boehringer Ingelheim GmbH Overview
        11.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Boehringer Ingelheim GmbH Recent Developments
    11.10 Corium International, Inc.
        11.10.1 Corium International, Inc. Corporation Information
        11.10.2 Corium International, Inc. Overview
        11.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Corium International, Inc. Recent Developments
    11.11 Echo Therapeutics, Inc.
        11.11.1 Echo Therapeutics, Inc. Corporation Information
        11.11.2 Echo Therapeutics, Inc. Overview
        11.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Echo Therapeutics, Inc. Recent Developments
    11.12 GlaxoSmithKline plc
        11.12.1 GlaxoSmithKline plc Corporation Information
        11.12.2 GlaxoSmithKline plc Overview
        11.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 GlaxoSmithKline plc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Active Transdermal Drug Delivery Device Industry Chain Analysis
    12.2 Active Transdermal Drug Delivery Device Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Active Transdermal Drug Delivery Device Production Mode & Process
    12.4 Active Transdermal Drug Delivery Device Sales and Marketing
        12.4.1 Active Transdermal Drug Delivery Device Sales Channels
        12.4.2 Active Transdermal Drug Delivery Device Distributors
    12.5 Active Transdermal Drug Delivery Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Active Transdermal Drug Delivery Device Industry Trends
    13.2 Active Transdermal Drug Delivery Device Market Drivers
    13.3 Active Transdermal Drug Delivery Device Market Challenges
    13.4 Active Transdermal Drug Delivery Device Market Restraints
14 Key Findings in The Global Active Transdermal Drug Delivery Device Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Patches
    Table 3. Major Manufacturers of Gels
    Table 4. Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Active Transdermal Drug Delivery Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Active Transdermal Drug Delivery Device Sales by Region (2017-2022) & (K Units)
    Table 7. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
    Table 8. Global Active Transdermal Drug Delivery Device Sales by Region (2023-2028) & (K Units)
    Table 9. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2023-2028)
    Table 10. Global Active Transdermal Drug Delivery Device Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2017-2022)
    Table 12. Global Active Transdermal Drug Delivery Device Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region (2023-2028)
    Table 14. Global Active Transdermal Drug Delivery Device Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Active Transdermal Drug Delivery Device Sales Share by Manufacturers (2017-2022)
    Table 16. Global Active Transdermal Drug Delivery Device Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Active Transdermal Drug Delivery Device Revenue Share by Manufacturers (2017-2022)
    Table 18. Active Transdermal Drug Delivery Device Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Active Transdermal Drug Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Active Transdermal Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Transdermal Drug Delivery Device as of 2021)
    Table 21. Active Transdermal Drug Delivery Device Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Active Transdermal Drug Delivery Device Product Offered
    Table 23. Date of Manufacturers Enter into Active Transdermal Drug Delivery Device Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
    Table 26. Global Active Transdermal Drug Delivery Device Sales by Type (2023-2028) & (K Units)
    Table 27. Global Active Transdermal Drug Delivery Device Sales Share by Type (2017-2022)
    Table 28. Global Active Transdermal Drug Delivery Device Sales Share by Type (2023-2028)
    Table 29. Global Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Active Transdermal Drug Delivery Device Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Active Transdermal Drug Delivery Device Revenue Share by Type (2017-2022)
    Table 32. Global Active Transdermal Drug Delivery Device Revenue Share by Type (2023-2028)
    Table 33. Active Transdermal Drug Delivery Device Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Active Transdermal Drug Delivery Device Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
    Table 36. Global Active Transdermal Drug Delivery Device Sales by Application (2023-2028) & (K Units)
    Table 37. Global Active Transdermal Drug Delivery Device Sales Share by Application (2017-2022)
    Table 38. Global Active Transdermal Drug Delivery Device Sales Share by Application (2023-2028)
    Table 39. Global Active Transdermal Drug Delivery Device Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Active Transdermal Drug Delivery Device Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Active Transdermal Drug Delivery Device Revenue Share by Application (2017-2022)
    Table 42. Global Active Transdermal Drug Delivery Device Revenue Share by Application (2023-2028)
    Table 43. Active Transdermal Drug Delivery Device Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Active Transdermal Drug Delivery Device Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
    Table 46. North America Active Transdermal Drug Delivery Device Sales by Type (2023-2028) & (K Units)
    Table 47. North America Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Active Transdermal Drug Delivery Device Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
    Table 50. North America Active Transdermal Drug Delivery Device Sales by Application (2023-2028) & (K Units)
    Table 51. North America Active Transdermal Drug Delivery Device Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Active Transdermal Drug Delivery Device Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
    Table 54. North America Active Transdermal Drug Delivery Device Sales by Country (2023-2028) & (K Units)
    Table 55. North America Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Active Transdermal Drug Delivery Device Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Active Transdermal Drug Delivery Device Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Active Transdermal Drug Delivery Device Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Active Transdermal Drug Delivery Device Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Active Transdermal Drug Delivery Device Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Active Transdermal Drug Delivery Device Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Active Transdermal Drug Delivery Device Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Active Transdermal Drug Delivery Device Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Active Transdermal Drug Delivery Device Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Active Transdermal Drug Delivery Device Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Active Transdermal Drug Delivery Device Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Active Transdermal Drug Delivery Device Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Active Transdermal Drug Delivery Device Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Active Transdermal Drug Delivery Device Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Active Transdermal Drug Delivery Device Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Active Transdermal Drug Delivery Device Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Active Transdermal Drug Delivery Device Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Active Transdermal Drug Delivery Device Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Active Transdermal Drug Delivery Device Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Active Transdermal Drug Delivery Device Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Active Transdermal Drug Delivery Device Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Active Transdermal Drug Delivery Device Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Novartis AG Corporation Information
    Table 106. Novartis AG Description and Major Businesses
    Table 107. Novartis AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Novartis AG Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Novartis AG Recent Developments
    Table 110. Noven Pharmaceuticals, Inc. Corporation Information
    Table 111. Noven Pharmaceuticals, Inc. Description and Major Businesses
    Table 112. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Noven Pharmaceuticals, Inc. Recent Developments
    Table 115. Transdermal Corp. Corporation Information
    Table 116. Transdermal Corp. Description and Major Businesses
    Table 117. Transdermal Corp. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Transdermal Corp. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Transdermal Corp. Recent Developments
    Table 120. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
    Table 121. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Major Businesses
    Table 122. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Developments
    Table 125. Mylan N.V. Corporation Information
    Table 126. Mylan N.V. Description and Major Businesses
    Table 127. Mylan N.V. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Mylan N.V. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Mylan N.V. Recent Developments
    Table 130. 3M Corporation Information
    Table 131. 3M Description and Major Businesses
    Table 132. 3M Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. 3M Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. 3M Recent Developments
    Table 135. Actavis, Inc. Corporation Information
    Table 136. Actavis, Inc. Description and Major Businesses
    Table 137. Actavis, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Actavis, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Actavis, Inc. Recent Developments
    Table 140. Bayer AG Corporation Information
    Table 141. Bayer AG Description and Major Businesses
    Table 142. Bayer AG Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Bayer AG Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Bayer AG Recent Developments
    Table 145. Boehringer Ingelheim GmbH Corporation Information
    Table 146. Boehringer Ingelheim GmbH Description and Major Businesses
    Table 147. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Boehringer Ingelheim GmbH Recent Developments
    Table 150. Corium International, Inc. Corporation Information
    Table 151. Corium International, Inc. Description and Major Businesses
    Table 152. Corium International, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Corium International, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Corium International, Inc. Recent Developments
    Table 155. Echo Therapeutics, Inc. Corporation Information
    Table 156. Echo Therapeutics, Inc. Description and Major Businesses
    Table 157. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Echo Therapeutics, Inc. Recent Developments
    Table 160. GlaxoSmithKline plc Corporation Information
    Table 161. GlaxoSmithKline plc Description and Major Businesses
    Table 162. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. GlaxoSmithKline plc Active Transdermal Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. GlaxoSmithKline plc Recent Developments
    Table 165. Key Raw Materials Lists
    Table 166. Raw Materials Key Suppliers Lists
    Table 167. Active Transdermal Drug Delivery Device Distributors List
    Table 168. Active Transdermal Drug Delivery Device Customers List
    Table 169. Active Transdermal Drug Delivery Device Market Trends
    Table 170. Active Transdermal Drug Delivery Device Market Drivers
    Table 171. Active Transdermal Drug Delivery Device Market Challenges
    Table 172. Active Transdermal Drug Delivery Device Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Active Transdermal Drug Delivery Device Product Picture
    Figure 3. Global Active Transdermal Drug Delivery Device Market Share by Type in 2021 & 2028
    Figure 3. Patches Product Picture
    Figure 4. Gels Product Picture
    Figure 5. Global Active Transdermal Drug Delivery Device Market Share by Application in 2021 & 2028
    Figure 6. Clinic
    Figure 7. Hospital
    Figure 8. Home Use
    Figure 9. Active Transdermal Drug Delivery Device Report Years Considered
    Figure 10. Global Active Transdermal Drug Delivery Device Sales 2017-2028 (K Units)
    Figure 11. Global Active Transdermal Drug Delivery Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Active Transdermal Drug Delivery Device Revenue 2017-2028 (US$ Million)
    Figure 13. Global Active Transdermal Drug Delivery Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2017-2022)
    Figure 15. Global Active Transdermal Drug Delivery Device Sales Market Share by Region (2023-2028)
    Figure 16. North America Active Transdermal Drug Delivery Device Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Active Transdermal Drug Delivery Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Active Transdermal Drug Delivery Device Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Active Transdermal Drug Delivery Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Active Transdermal Drug Delivery Device Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Active Transdermal Drug Delivery Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Active Transdermal Drug Delivery Device Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Active Transdermal Drug Delivery Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Active Transdermal Drug Delivery Device Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Active Transdermal Drug Delivery Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Active Transdermal Drug Delivery Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Active Transdermal Drug Delivery Device in the World: Market Share by Active Transdermal Drug Delivery Device Revenue in 2021
    Figure 28. Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2028)
    Figure 30. Global Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2028)
    Figure 31. Global Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2028)
    Figure 32. Global Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2028)
    Figure 33. North America Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2028)
    Figure 34. North America Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2028)
    Figure 35. North America Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2028)
    Figure 36. North America Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2028)
    Figure 37. North America Active Transdermal Drug Delivery Device Sales Share by Country (2017-2028)
    Figure 38. North America Active Transdermal Drug Delivery Device Revenue Share by Country (2017-2028)
    Figure 39. U.S. Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2028)
    Figure 42. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2028)
    Figure 44. Europe Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Active Transdermal Drug Delivery Device Sales Share by Country (2017-2028)
    Figure 46. Europe Active Transdermal Drug Delivery Device Revenue Share by Country (2017-2028)
    Figure 47. Germany Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 48. France Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Active Transdermal Drug Delivery Device Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Active Transdermal Drug Delivery Device Revenue Share by Region (2017-2028)
    Figure 58. China Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 61. India Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Active Transdermal Drug Delivery Device Sales Share by Country (2017-2028)
    Figure 73. Latin America Active Transdermal Drug Delivery Device Revenue Share by Country (2017-2028)
    Figure 74. Mexico Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Active Transdermal Drug Delivery Device Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Active Transdermal Drug Delivery Device Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Active Transdermal Drug Delivery Device Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Active Transdermal Drug Delivery Device Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Active Transdermal Drug Delivery Device Revenue Share by Country (2017-2028)
    Figure 83. Turkey Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Active Transdermal Drug Delivery Device Revenue (2017-2028) & (US$ Million)
    Figure 86. Active Transdermal Drug Delivery Device Value Chain
    Figure 87. Active Transdermal Drug Delivery Device Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Frequently Asked Questions
Active Transdermal Drug Delivery Device report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Active Transdermal Drug Delivery Device report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Active Transdermal Drug Delivery Device report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Biometrics Banking

Biometrics Banking market is segmented by players, region (country), by Type and by Application.  ... Read More

Blemish Balm Product

Blemish Balm Product market is segmented by Type and by Application. Players, stakeholders, and o ... Read More